VIVUS, Inc. - VVUS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

VIVUS, Inc. - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
VVUS	Nasdaq	2834	http://www.vivus.com/	14.82 +0.32
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for VIVUS, Inc. 3 Humongous Health Care Stocks This Week - May 24th, 2013 2:18 pm What's behind put trading in Vivus - May 24th, 2013 9:02 am Why This Obesity Drug Is the Sector's Best Bet - May 24th, 2013 8:27 am Novo obesity drug could launch in U.S. end 2014 - May 24th, 2013 4:20 am Vivus Heats Up, Shorts Discouraged On Possible Bidding War - May 24th, 2013 3:41 am Arena - Good Sales, Bad Sales, Long And Short - May 24th, 2013 12:53 am First Manhattan Still Playing Hardball With Vivus - May 23rd, 2013 10:06 pm Denner added as nominee to Vivus board by activist investor - May 23rd, 2013 2:51 pm Bullish Two Hundred Day Moving Average Cross - VVUS - May 23rd, 2013 2:21 pm [video] Options Activity Ahead of Pandora Earnings - May 23rd, 2013 1:26 pm [video] Nasdaq Check: Tech Stocks Recover - May 23rd, 2013 11:02 am Alex Denner Joins Vivus Activist Slate in Post-Icahn Move - May 23rd, 2013 7:35 am InPlay: Vivus: First Manhattan adds Alex Denner to Vivus Board slate; Denner's Sarissa Capital Management owns 2 mln Vivus shares - May 23rd, 2013 4:31 am First Manhattan Adds Alex Denner to Vivus Board Slate - May 23rd, 2013 4:30 am 3 Pipeline Obesity Treatments You Should Watch - May 22nd, 2013 6:56 pm VIVUS Announces Scientific Presentations - May 22nd, 2013 5:00 am Arena Pharmaceuticals - Out To Launch Or Out To Lunch? - May 22nd, 2013 1:19 am VIVUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation o - May 21st, 2013 7:06 am The Facebook Effect On Arena's Belviq Sales And Why It Will Ultimately Dwarf Anything Eisai Does - May 21st, 2013 4:56 am The 9 Most Obese Countries in the World - May 20th, 2013 12:06 pm View All Current Headlines >>